Manufacturer
SANOFI-AVENTIS, S.A
Contents
Hydroxychloroquine sulphate
Indication
Acute malaria, Discoid and systemic lupus erythematosus, RA (rheumatoid arthritis), Prophylaxis of malaria.
Instruction
Should be taken with food.
Drug interaction
Hydroxychloroquine may enhance the effect of hypoglycaemic agents. May increase plasma digoxin level. Increased risk of Torsades de pointes w/ QTc-prolonging agents (e.g. disopyramide, quinidine, amiodarone, sotalol, cisapride). Increased risk of convulsion w/ mefloquine. Antacids may interfere w/ hydroxychloroquine absorption.
SANOFI-AVENTIS, S.A
Contents
Hydroxychloroquine sulphate
Indication
Acute malaria, Discoid and systemic lupus erythematosus, RA (rheumatoid arthritis), Prophylaxis of malaria.
Instruction
Should be taken with food.
Drug interaction
Hydroxychloroquine may enhance the effect of hypoglycaemic agents. May increase plasma digoxin level. Increased risk of Torsades de pointes w/ QTc-prolonging agents (e.g. disopyramide, quinidine, amiodarone, sotalol, cisapride). Increased risk of convulsion w/ mefloquine. Antacids may interfere w/ hydroxychloroquine absorption.
Inquiry - Plaquenil Tablets